Back to search

Article

In silico synergistic drug repurposing for combating novel coronavirus (COVID-19) outbreaks

2020-04-07

Abstract excerpt

As the number of novel coronavirus (COVID-19) cases continues to rise, there is a global need for rapid drug development. In this study, we propose a systems pharmacology approach to reposition FDA-approved drug candidates for coronavirus, identify targets and suggest a synergistic drug combination using network pharmacology. We collected 67 genes associated with coronavirus, performed an enrichment analysis to ob...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bbc53b28-3f0d-5c78-9498-62a0a280ecb6
DOI
10.21203/rs.3.rs-21849/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In silico synergistic drug repurposing for combating novel coronavirus (COVID-19) outbreaksDOI 10.21203/rs.3.rs-21849/v1
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysisSemantic proximity
A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity
A Network-Biology Led Computational Drug Repurposing Strategy to Prioritize Therapeutic Options for COVID-19Semantic proximity
A Network-Biology led Computational Drug repurposing Strategy to prioritize therapeutic options for COVID-19Semantic proximity
A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity
Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity
Ontological and Bioinformatic Analysis of Anti-Coronavirus Drugs and Their Implication for Drug Repurposing against COVID-19Semantic proximity
Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity
Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity
Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity
Depicting the innate immune response landscape in Covid-19 emphasized type 1 interferon a key defense against SARS-CoV-2Semantic proximity
A Hybrid AI-driven Algorithm to Uncover Potential Therapeutic Targets for COVID-19 Using Network-based Drug RepurposingSemantic proximity
Select a neighboring publication to make it the new centre.